We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MYLAN REJOINS PENNSYLVANIA PACE DRUG PROGRAM -- WITH CONDITIONS
MYLAN REJOINS PENNSYLVANIA PACE DRUG PROGRAM -- WITH CONDITIONS
February 18, 2004
Reversing an earlier decision, generic drugmaker Mylan Laboratories has rejoined Pennsylvania’s $400 million prescription drug discount program on the condition that state officials work to lower the required rebate on generic drugs to 11 percent.